Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
CALL
Toro Company
TTC
$9.5B
| $12.9M | ﹤0.01% |
113,800
+8,600
| +8% | +$911K |
|
1927
National Health Investors
NHI
$3.56B
| $12.9M | ﹤0.01% |
246,428
+103,005
| +72% | +$5.65M |
|
1928
Equifax
EFX
$22.4B
| $12.9M | ﹤0.01% |
66,195
+17,526
| +36% | +$3.2M |
|
|
UMPQ
1929
DELISTED
Umpqua Holdings Corp
UMPQ
| $12.9M | ﹤0.01% |
720,631
-66,958
| -9% | -$1.26M |
|
1930
CALL
Pan American Silver
PAAS
$22.6B
| $12.9M | ﹤0.01% |
787,100
+151,200
| +24% | +$2.42M |
|
1931
PUT
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$37.1M
| $12.9M | ﹤0.01% |
78,600
-18,467
| -19% | -$3.39M |
|
1932
Ovintiv
OVV
$18.1B
| $12.9M | ﹤0.01% |
253,424
-175,231
| -41% | -$9.16M |
|
1933
Alliance Resource Partners
ARLP
$3.39B
| $12.8M | ﹤0.01% |
631,039
+213,321
| +51% | +$4.83M |
|
1934
CALL
Gold Fields
GFI
$42.7B
| $12.8M | ﹤0.01% |
1,238,600
+308,700
| +33% | +$2.99M |
|
1935
PUT
Yeti Holdings
YETI
$3.04B
| $12.8M | ﹤0.01% |
310,300
+66,900
| +27% | +$2.51M |
|
1936
KKR & Co
KKR
$97.8B
| $12.8M | ﹤0.01% |
275,810
-300,621
| -52% | -$14.7M |
|
1937
VICI Properties
VICI
$28.4B
| $12.8M | ﹤0.01% |
395,047
+286,547
| +264% | +$9.21M |
|
1938
CALL
Jazz Pharmaceuticals
JAZZ
$16.3B
| $12.8M | ﹤0.01% |
80,300
-74,600
| -48% | -$10.9M |
|
1939
CALL
Roper Technologies
ROP
$41.6B
| $12.8M | ﹤0.01% |
29,600
+2,500
| +9% | +$1.03M |
|
1940
Fastenal
FAST
$58.7B
| $12.8M | ﹤0.01% |
539,736
+233,232
| +76% | +$5.7M |
|
1941
CALL
ScottsMiracle-Gro
SMG
$3.56B
| $12.8M | ﹤0.01% |
262,800
+167,300
| +175% | +$8.38M |
|
1942
PUT
Raymond James Financial
RJF
$33.7B
| $12.8M | ﹤0.01% |
119,500
+11,800
| +11% | +$1.32M |
|
1943
PUT
CONMED
CNMD
$1.5B
| $12.7M | ﹤0.01% |
143,600
+66,500
| +86% | +$5.52M |
|
1944
PUT
Ares Capital
ARCC
$14.3B
| $12.7M | ﹤0.01% |
688,300
-1,881,300
| -73% | -$35.3M |
|
1945
PUT
Celanese
CE
$4.89B
| $12.7M | ﹤0.01% |
124,200
+32,200
| +35% | +$3.19M |
|
1946
iShares Biotechnology ETF
IBB
$10.8B
| $12.7M | ﹤0.01% |
96,601
-31,242
| -24% | -$4.04M |
|
1947
Annaly Capital Management
NLY
$17.4B
| $12.7M | ﹤0.01% |
601,235
+540,092
| +883% | +$10.6M |
|
|
1948
PUT
Jazz Pharmaceuticals
JAZZ
$16.3B
| $12.7M | ﹤0.01% |
79,500
+13,900
| +21% | +$2.04M |
|
1949
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$460M
| $12.7M | ﹤0.01% |
178,000
+85,200
| +92% | +$5.63M |
|
1950
ProShares Ultra Bloomberg Crude Oil
UCO
$389M
| $12.6M | ﹤0.01% |
+417,104
| New | +$12.6M |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.